Dimensional Fund Advisors LP Vbi Vaccines Inc Transaction History

Dimensional Fund Advisors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.73 - $23.4 $3,717 - $119,152	-5,092 Reduced 6.07%	78,741 $56,000
Q2 2022 Aug 12, 2022	SELL	$0.66 - $1.81 $13,434 - $36,842	-20,355 Reduced 19.54%	83,833 $68,000
Q1 2022 May 13, 2022	SELL	$1.27 - $2.47 $90,369 - $175,757	-71,157 Reduced 40.58%	104,188 $173,000
Q4 2021 Feb 09, 2022	BUY	$2.21 - $3.22 $356,077 - $518,809	161,121 Added 1132.74%	175,345 $410,000
Q3 2021 Nov 12, 2021	BUY	$2.8 - $3.72 $1,805 - $2,399	645 Added 4.75%	14,224 $44,000
Q2 2021 Aug 12, 2021	BUY	$2.61 - $4.17 $35,441 - $56,624	13,579 New	13,579 $45,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.